SALKIND GENE enters UPEXI, INC. with 2.35M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/24/2021ACC: 0001477932-21-004240
Director10% Owner
2.35M
Baseline shares
100% direct
2.35M
Direct ownership
1 position
27.78K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2.35M
Total
2.35M direct2.35M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.35M | Direct |
| Total | 2.35M | 2.35M direct |
Derivative Holdings1
Director Stock Option Grant
DirectUnderlying security
Common Stock
Underlying shares
27.78K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
27.78K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Director Stock Option Grant Direct | Common Stock | — | — | 27.78K | N/A | |
| Total | 27.78K | 0.00 | ||||